Evergreen Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.27M | Buy |
8,134
+4,253
| +110% | +$2.23M | 0.13% | 175 |
|
|
2025
Q1 | $2.46M | Buy |
3,881
+16
| +0.4% | +$10.1K | 0.08% | 224 |
|
|
2024
Q4 | $2.75M | Buy |
3,865
+3,030
| +363% | +$2.16M | 0.09% | 210 |
|
|
2024
Q3 | $878K | Sell |
835
-2,860
| -77% | -$3.01M | 0.03% | 347 |
|
|
2024
Q2 | $3.88M | Buy |
3,695
+55
| +2% | +$57.8K | 0.14% | 168 |
|
|
2024
Q1 | $3.5M | Sell |
3,640
-1,291
| -26% | -$1.24M | 0.13% | 174 |
|
|
2023
Q4 | $4.33M | Sell |
4,931
-92
| -2% | -$80.8K | 0.18% | 151 |
|
|
2023
Q3 | $4.13M | Sell |
5,023
-2,091
| -29% | -$1.72M | 0.18% | 148 |
|
|
2023
Q2 | $5.11M | Buy |
7,114
+87
| +1% | +$62.5K | 0.21% | 132 |
|
|
2023
Q1 | $5.77M | Sell |
7,027
-25
| -0.4% | -$20.5K | 0.26% | 113 |
|
|
2022
Q4 | $5.09M | Sell |
7,052
-74
| -1% | -$53.4K | 0.24% | 123 |
|
|
2022
Q3 | $4.91M | Sell |
7,126
-118
| -2% | -$81.3K | 0.26% | 114 |
|
|
2022
Q2 | $4.28M | Buy |
7,244
+2,728
| +60% | +$1.61M | 0.22% | 124 |
|
|
2022
Q1 | $3.15M | Buy |
4,516
+66
| +1% | +$46.1K | 0.13% | 190 |
|
|
2021
Q4 | $2.81M | Buy |
4,450
+437
| +11% | +$276K | 0.11% | 199 |
|
|
2021
Q3 | $2.43M | Sell |
4,013
-1,324
| -25% | -$801K | 0.11% | 194 |
|
|
2021
Q2 | $2.98M | Buy |
5,337
+119
| +2% | +$66.5K | 0.14% | 161 |
|
|
2021
Q1 | $2.47M | Buy |
+5,218
| New | +$2.47M | 0.13% | 174 |
|